Physician profile
Bruce E Prum
NPI 1710056353
$3,421.40
in general payments reported to CMS, 2019-2025
11 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $83.69 · 2021: $210 · 2022: $401 · 2023: $627 · 2024: $660 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,043.15 | 2022-2025 | |
| Allergan, INC. | $692.21 | 2019-2021 | |
| Alcon Vision LLC | $508.30 | 2019-2024 | Hydrus Microstent, Argos |
| Sight Sciences, INC. | $416.46 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Nova Eye, INC. | $156.90 | 2025 | |
| Genentech USA, INC. | $124.73 | 2024 | Vabysmo |
| Omeros Corporation | $113.10 | 2019-2021 | |
| Alimera Sciences, INC. | $105.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $104.95 | 2019 | |
| Biotissue Holdings INC. | $89.91 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $66.17 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Prum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.